Literature DB >> 642151

An apparently effective countermeasure for doxorubicin extravasation.

J I Zweig, B Kabakow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 642151     DOI: 10.1001/jama.1978.03280470028013

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Savene® (dexrazoxane) use in clinical practice.

Authors:  Christel Fontaine; Luc Noens; Pascal Pierre; Jacques De Grève
Journal:  Support Care Cancer       Date:  2012-01-27       Impact factor: 3.603

2.  Use of sodium bicarbonate as a means of ameliorating doxorubicin-induced dermal necrosis in rats.

Authors:  L Bartkowski-Dodds; J R Daniels
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 3.  Cancer chemotherapy agent-induced perivenous extravasation injuries.

Authors:  A Banerjee; T M Brotherston; B G Lamberty; R C Campbell
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

Review 4.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

5.  The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.

Authors:  R T Dorr; D S Alberts; H S Chen
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

6.  Soft-tissue necrosis induced by extravasated cancer chemotherapeutic agents: a study of active intervention.

Authors:  R D Barr; J Sertic
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.